Fundraising FoxShepherd Ventures — 2021 Investments
1 investments dated 2021 · listed companies and verified rows first · show all
AmplifiDx develops point-of-care molecular diagnostic tests and its DX 100 platform for family, women's, and sexual health, targeting infectious disease detection for healthcare professionals and patients.
BiotechDigital HealthFemTechHealthtechMedical DevicesPleasanton, US
Nancy Schoenbrunner(Chief Executive Officer)inShoulian Dong(Chief Scientific Officer)Daniel Schoener(Chief Product Officer)inChris Meda(Chief Commercial Officer)inMing Tan(Director)Sammy Datwani(Director)
Co-investorsAvestria VenturesBeacon AngelsSocial Starts
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.